- Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.
The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.
4 reports, 4 independent
Updated Sun 00:00
No new developments lately
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Collins spoke on VA goals as the administration moves to accelerate drug approvals via executive order.1 source
- Donald Trump instructed the FDA to accelerate the drug review process.Sub-event
Executive order signed and priority vouchers issued to accelerate drug approval via FDA.1 source
Keep exploring
The entities involved
- FDA
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Marty Makary
American surgeon and FDA Commissioner
Nothing else this week.